Clinicostatistical analyses of medication‐related osteonecrosis of the jaws (MRONJ): Evaluation of the treatment method and prognosis

Objective Medication‐related osteonecrosis of the jaw (MRONJ) is an adverse event associated with the use of antiresorptive agents such as bisphosphonate (BP) and denosumab (Dmab). The major clinical symptoms of MRONJ are progressive destruction of the jaw, prolonged pain, bone exposure, soft tissue swelling, fistula, and infections. These symptoms influence the patients’ quality of life. However, there is no consensus on the appropriate...